Publications by Mark Yarchoan
- Clinical Guideline for the Diagnosis and Treatment of Fibrolamellar Carcinoma (FLC)
- Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma
- DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
- DNAJ-PKAc induces metabolic wiring and enhanced glutamine flux in fibrolamellar HCC
- Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
- Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma
- Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
- A Therapeutic Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma: A Phase 1 Trial